|
The impact of phthalate on reproductive function in women with endometriosis
|
2024-06-18 |
|
Integration of genome-wide association study and expression quantitative trait locus mapping for identification of endometriosis-associated genes
|
2024-06-18 |
|
Evaluation of adenomyosis after gonadotrophin-releasing hormone agonist therapy using ultrasound post-processing imaging: a pilot study
|
2024-06-18 |
|
Killer cell immunoglobulinlike receptors (KIR) and human leukocyte antigen-C (HLA-C) allorecognition patterns in women with endometriosis
|
2024-06-18 |
|
Exposure to Mono-n-Butyl Phthalate in Women with Endometriosis and Its Association with the Biological Effects on Human Granulosa Cells
|
2024-06-18 |
|
Decreased Level of Neurotrophic Factor Neuritin 1 in Women With Ovarian Endometriosis After Receiving Gonadotropin-Releasing Hormone Agonist Treatment
|
2024-06-18 |
|
Reply to: Adhesion proteins: Suitable therapeutic targets or biomarkers of therapy response for endometriosis?
|
2024-06-18 |
|
Chronic Niche Inflammation in Endometriosis-Associated Infertility: Current Understanding and Future Therapeutic Strategies
|
2024-06-18 |
|
Gonadotropin-releasing hormone agonist induces downregulation of tensin 1 in women with endometriosis.
|
2024-06-18 |
|
Women with adenomyosis are at higher risks of endometrial and thyroid cancers: A population-based historical cohort study
|
2024-06-18 |
